Changes in insulin and IGF-I receptor expression during differentiation of human preadipocytes

Growth Hormone and IGF Research

Volumn 19, Issue 2, 2009, Pages 101-111

  Bäck, Karolina ^a   Arnqvist, Hans J ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Cell metabolism; Growth factors; Insulin receptor isoforms

Indexed keywords

ADIPONECTIN; DEXAMETHASONE; DNA; GLUCOSE; GLUCOSE TRANSPORTER 4; GROWTH HORMONE RECEPTOR; INDOMETACIN; INSULIN; INSULIN RECEPTOR; ISOBUTYLMETHYLXANTHINE; LIGAND; SOMATOMEDIN C RECEPTOR; THYMIDINE;

ADIPOCYTE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOPRECIPITATION; ISOTOPE LABELING; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; STIMULATION; WESTERN BLOTTING;

ADIPOCYTES; ADULT; ADULT STEM CELLS; AGED; AGED, 80 AND OVER; ANTIGENS, DIFFERENTIATION; CELL DIFFERENTIATION; CELLS, CULTURED; FEMALE; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; MIDDLE AGED; PHOSPHORYLATION; RECEPTOR, IGF TYPE 1; RECEPTOR, INSULIN;

EID: 61649083311     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2008.06.004     Document Type: Article

References (37)

1. Ryden M., Dicker A., Gotherstrom C., Astrom G., Tammik C., Arner P., and Le Blanc K. Functional characterization of human mesenchymal stem cell-derived adipocytes. Biochemical and Biophysical Research Communications 311 (2003) 391-397
2. Rodriguez A.M., Elabd C., Delteil F., Astier J., Vernochet C., Saint-Marc P., Guesnet J., Guezennec A., Amri E.Z., Dani C., and Ailhaud G. Adipocyte differentiation of multipotent cells established from human adipose tissue. Biochemical and Biophysical Research Communications 315 (2004) 255-263
3. Mackay D.L., Tesar P.J., Liang L.N., and Haynesworth S.E. Characterizing medullary and human mesenchymal stem cell-derived adipocytes. Journal of Cellular Physiology 207 (2006) 722-728
4. Gustafson B., Jack M.M., Cushman S.W., and Smith U. Adiponectin gene activation by thiazolidinediones requires PPAR gamma 2, but not C/EBP alpha-evidence for differential regulation of the aP2 and adiponectin genes. Biochemical and Biophysical Research Communications 308 (2003) 933-939
5. Lin F.T., and Lane M.D. Antisense CCAAT/enhancer-binding protein RNA suppresses coordinate gene expression and triglyceride accumulation during differentiation of 3T3-L1 preadipocytes. Genes & Development 6 (1992) 533-544
6. Park S.K., Oh S.Y., Lee M.Y., Yoon S., Kim K.S., and Kim J.W. CCAAT/enhancer binding protein and nuclear factor-Y regulate adiponectin gene expression in adipose tissue. Diabetes 53 (2004) 2757-2766
7. Wei Y., Rhani Z., and Goodyer C.G. Characterization of growth hormone receptor messenger ribonucleic acid variants in human adipocytes. The Journal of Clinical Endocrinology and Metabolism 91 (2006) 1901-1908
8. Entingh-Pearsall A., and Kahn C.R. Differential roles of the insulin and insulin-like growth factor-I (IGF-I) receptors in response to insulin and IGF-I. The Journal of Biological Chemistry 279 (2004) 38016-38024
9. Ullrich A., Gray A., Tam A.W., Yang-Feng T., Tsubokawa M., Collins C., Henzel W., Le Bon T., Kathuria S., Chen E., et al. Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. The EMBO Journal 5 (1986) 2503-2512
10. Blakesley V.A., Scrimgeour A., Esposito D., and Le Roith D. Signaling via the insulin-like growth factor-I receptor: does it differ from insulin receptor signaling?. Cytokine & Growth Factor Reviews 7 (1996) 153-159
11. Lammers R., Gray A., Schlessinger J., and Ullrich A. Differential signalling potential of insulin- and IGF-1-receptor cytoplasmic domains. The EMBO Journal 8 (1989) 1369-1375
12. Bouzakri K., Zachrisson A., Al-Khalili L., Zhang B.B., Koistinen H.A., Krook A., and Zierath J.R. siRNA-based gene silencing reveals specialized roles of IRS-1/Akt2 and IRS-2/Akt1 in glucose and lipid metabolism in human skeletal muscle. Cell Metabolism 4 (2006) 89-96
13. Frasca F., Pandini G., Scalia P., Sciacca L., Mineo R., Costantino A., Goldfine I.D., Belfiore A., and Vigneri R. Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells. Molecular and Cellular Biology 19 (1999) 3278-3288
14. Mosthaf L., Grako K., Dull T.J., Coussens L., Ullrich A., and McClain D.A. Functionally distinct insulin receptors generated by tissue-specific alternative splicing. The EMBO Journal 9 (1990) 2409-2413
15. Denley A., Bonython E.R., Booker G.W., Cosgrove L.J., Forbes B.E., Ward C.W., and Wallace J.C. Structural determinants for high-affinity binding of insulin-like growth factor II to insulin receptor (IR)-A, the exon 11 minus isoform of the IR. Molecular Endocrinology (Baltimore, Md) 18 (2004) 2502-2512
16. Serrano R., Villar M., Martinez C., Carrascosa J.M., Gallardo N., and Andres A. Differential gene expression of insulin receptor isoforms A and B and insulin receptor substrates 1, 2 and 3 in rat tissues: modulation by aging and differentiation in rat adipose tissue. Journal of Molecular Endocrinology 34 (2005) 153-161
17. Sesti G., Federici M., Lauro D., Sbraccia P., and Lauro R. Molecular mechanism of insulin resistance in type 2 diabetes mellitus: role of the insulin receptor variant forms. Diabetes/Metabolism Research and Reviews 17 (2001) 363-373
18. Soos M.A., Field C.E., and Siddle K. Purified hybrid insulin/insulin-like growth factor-I receptors bind insulin-like growth factor-I, but not insulin, with high affinity. The Biochemical Journal 290 Pt 2 (1993) 419-426
19. Bailyes E.M., Nave B.T., Soos M.A., Orr S.R., Hayward A.C., and Siddle K. Insulin receptor/IGF-I receptor hybrids are widely distributed in mammalian tissues: quantification of individual receptor species by selective immunoprecipitation and immunoblotting. The Biochemical Journal 327 Pt 1 (1997) 209-215
20. Pandini G., Vigneri R., Costantino A., Frasca F., Ippolito A., Fujita-Yamaguchi Y., Siddle K., Goldfine I.D., and Belfiore A. Insulin and insulin-like growth factor-I (IGF-I) receptor overexpression in breast cancers leads to insulin/IGF-I hybrid receptor overexpression: evidence for a second mechanism of IGF-I signaling. Clinical Cancer Research 5 (1999) 1935-1944
21. Nitert M.D., Chisalita S.I., Olsson K., Bornfeldt K.E., and Arnqvist H.J. IGF-I/insulin hybrid receptors in human endothelial cells. Molecular and Cellular Endocrinology 229 (2005) 31-37
22. Chisalita S.I., Nitert M.D., and Arnqvist H.J. Characterisation of receptors for IGF-I and insulin; evidence for hybrid insulin/IGF-I receptor in human coronary artery endothelial cells. Growth Hormone & IGF Research 16 (2006) 258-266
23. Karlsson M., Thorn H., Danielsson A., Stenkula K.G., Ost A., Gustavsson J., Nystrom F.H., and Stralfors P. Colocalization of insulin receptor and insulin receptor substrate-1 to caveolae in primary human adipocytes. Cholesterol depletion blocks insulin signalling for metabolic and mitogenic control. European Journal of Biochemistry/FEBS 271 (2004) 2471-2479
24. Huss F.R., and Kratz G. Adipose tissue processed for lipoinjection shows increased cellular survival in vitro when tissue engineering principles are applied. Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery/Nordisk Plastikkirurgisk Forening [and] Nordisk Klubb for Handkirurgi 36 (2002) 166-171
25. Smith P.J., Wise L.S., Berkowitz R., Wan C., and Rubin C.S. Insulin-like growth factor-I is an essential regulator of the differentiation of 3T3-L1 adipocytes. The Journal of Biological Chemistry 263 (1988) 9402-9408
26. Shimizu M., Torti F., and Roth R.A. Characterization of the insulin and insulin-like growth factor receptors and responsitivity of a fibroblast/adipocyte cell line before and after differentiation. Biochemical and Biophysical Research Communications 137 (1986) 552-558
27. Scavo L.M., Karas M., Murray M., and Leroith D. Insulin-like growth factor-I stimulates both cell growth and lipogenesis during differentiation of human mesenchymal stem cells into adipocytes. The Journal of Clinical Endocrinology and Metabolism 89 (2004) 3543-3553
28. Zou L., Menon R.K., and Sperling M.A. Induction of mRNAs for the growth hormone receptor gene during mouse 3T3-L1 preadipocyte differentiation. Metabolism: Clinical and Experimental 46 (1997) 114-118
29. Wang B., Jenkins J.R., and Trayhurn P. Expression and secretion of inflammation-related adipokines by human adipocytes differentiated in culture: integrated response to TNF-alpha. American Journal of Physiology 288 (2005) E731-E740
30. Wu Z., Xie Y., Morrison R.F., Bucher N.L., and Farmer S.R. PPARgamma induces the insulin-dependent glucose transporter GLUT4 in the absence of C/EBPalpha during the conversion of 3T3 fibroblasts into adipocytes. The Journal of Clinical Investigation 101 (1998) 22-32
31. Kellerer M., Lammers R., Ermel B., Tippmer S., Vogt B., Obermaier-Kusser B., Ullrich A., and Haring H.U. Distinct alpha-subunit structures of human insulin receptor A and B variants determine differences in tyrosine kinase activities. Biochemistry 31 (1992) 4588-4596
32. Fischer-Posovszky P., Tornqvist H., Debatin K.M., and Wabitsch M. Inhibition of death-receptor mediated apoptosis in human adipocytes by the insulin-like growth factor I (IGF-I)/IGF-I receptor autocrine circuit. Endocrinology 145 (2004) 1849-1859
33. Westergren H., Danielsson A., Nystrom F.H., and Stralfors P. Glucose transport is equally sensitive to insulin stimulation, but basal and insulin-stimulated transport is higher, in human omental compared with subcutaneous adipocytes. Metabolism: Clinical and Experimental 54 (2005) 781-785
34. Chisalita S.I., and Arnqvist H.J. Insulin-like growth factor I receptors are more abundant than insulin receptors in human micro- and macrovascular endothelial cells. American Journal of Physiology 286 (2004) E896-E901
35. Engeli S., Feldpausch M., Gorzelniak K., Hartwig F., Heintze U., Janke J., Mohlig M., Pfeiffer A.F., Luft F.C., and Sharma A.M. Association between adiponectin and mediators of inflammation in obese women. Diabetes 52 (2003) 942-947
36. Al-Khalili L., Forsgren M., Kannisto K., Zierath J.R., Lonnqvist F., and Krook A. Enhanced insulin-stimulated glycogen synthesis in response to insulin, metformin or rosiglitazone is associated with increased mRNA expression of GLUT4 and peroxisomal proliferator activator receptor gamma co-activator 1. Diabetologia 48 (2005) 1173-1179
37. Sutinen J., Kannisto K., Korsheninnikova E., Fisher R.M., Ehrenborg E., Nyman T., Virkamaki A., Funahashi T., Matsuzawa Y., Vidal H., Hamsten A., and Yki-Jarvinen H. Effects of rosiglitazone on gene expression in subcutaneous adipose tissue in highly active antiretroviral therapy-associated lipodystrophy. American Journal of Physiology 286 (2004) E941-E949